Evidence map›Paper›PMID 28388005›Full record

ArticleChembiochem : a European journal of chemical biology2017

A New Methodology for Incorporating Chiral Linkers into Stapled Peptides.

Juan C Serrano, James Sipthorp, Wenshu Xu, Laura S Itzhaki, Steven V Ley

Open access · hybridAbstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Recognition of ASF1 by Using Hydrocarbon-Constrained Peptides.Chembiochem : a European journal of chemical biology · 2019
    Article
  8. Review
  9. Review
  10. A New Methodology for Incorporating Chiral Linkers into Stapled Peptides.Chembiochem : a European journal of chemical biology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Juan C SerranoDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.ORCID 0000-0002-3671-3809
James SipthorpDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.ORCID 0000-0002-6838-8043
Wenshu XuDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK.
Laura S ItzhakiDepartment of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK.ORCID 0000-0001-6504-2576
Steven V LeyDepartment of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.ORCID 0000-0002-7816-0042
University of Cambridge · GB

Funding

Medical Research Council G1002329Medical Research Council MC_PC_13059Medical Research Council MC_PC_14116MRF_ C0385
6 · The paper itself

Abstract

Stapled peptides have arisen as a new class of chemical probe and potential therapeutic agents for modulating protein-protein interactions. Here, we report the first two-component i,i+7 stapling methodology that makes use of two orthogonal, on-resin stapling reactions to incorporate linkers bearing a chiral centre into a p53-derived stapled peptide. Post-stapling modifications to the chain were performed on-resin and enabled rapid access to various peptide derivatives from a single staple. The stapled peptides have increased helicity, protease stability and in vitro binding affinities to MDM2 compared to the equivalent unstapled peptide. This approach can be used to generate a library of diverse stapled peptides with different properties starting from a single stapled peptide, with scope for much greater functional diversity than that provided by existing stapling methodologies.

Indexed as

AlanineBenzhydryl CompoundsCell Line, TumorCross-Linking ReagentsHumansPeptide LibraryPeptidesProtein BindingProtein StabilityProtein Structure, SecondaryProto-Oncogene Proteins c-mdm2Solid-Phase Synthesis TechniquesTumor Suppressor Protein p534-methylbenzhydrylamine resinAlanineazidohomoalanineBenzhydryl CompoundsCross-Linking ReagentsMDM2 protein, humanPeptide LibraryPeptidesProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53chiral linkersprotein-protein interactionssolid-phase synthesisstapled peptidestwo-component stapling

Identifiers

PMID28388005
PMCPMC5488175
OpenAlexW2604307388

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.